House Republicans aim to block board's Medicare authority

Share this article:
House Speaker John Boehner (R-OH)
House Speaker John Boehner (R-OH)

Republican House leaders say they will continue to fight a part of the healthcare reform law that could lead to Medicare spending reductions without direct input from Congress. The House was scheduled to vote on rules for the 113th Congress Thursday. Part of them would include a GOP-promoted package that would disallow powers of the Independent Payment Advisory Board (IPAB). 

 

With the expected vote, Republicans could ignore Medicare spending cuts recommended by the IPAB. A panel of 15 healthcare experts, IPAB would take many Medicare payment decisions out of Congress' hands. It is seen roughly as a replacement for the Medicare Payment Advisory Commission, which can only make recommendations to, with no binding authority over, Congress. IPAB is the central cost-cutting feature of the Affordable Care Act and is empowered to suggest savings if spending rises above a benchmark. It can't cut benefits.

 

The health reform law requires the House to review IPAB recommendations immediately and House committees to pass them expediently. Congress can change IPAB recommendations if similar savings can be created in the budgeting process.

 

The rules could be challenged because they seek to override a law. If that doesn't occur, the House could follow any rules it adopts this week.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.